A previous study showed that sustained deficiency of ADAM17 in the epidermis of wild‐type mice results in epidermal barrier defects, and subsequently dermatitis and myeloproliferative disease; that is, a significant increase in the myeloid‐cell infiltration 20. This evidence concerns the gene ADAM17 and skin disorder.